Filling the need for trusted information on national health issues…

Intellectual Property and Trade

  • Your Selections:

Refine Results

date

Tags

CGD Blog Post Discusses Research On Impact Of Patents On Drug Availability

Center for Global Development’s “Global Health Policy Blog”: What Drug Patents Do Is Complicated: A Belated Contribution from Jenny Lanjouw Helps Sort It Out Kimberly Ann Elliott, senior fellow at CGD, discusses research by former CGD fellow Jenny Lanjouw and her coauthors, Iain Cockburn and Mark Schankerman, on patents and…

GlaxoSmithKline Taking Steps To Help Reduce Drug Prices In Lower-Income Countries

The Guardian: GlaxoSmithKline to lower drug prices in poorer countries “GlaxoSmithKline is taking action to make medicines more affordable in developing countries, including waiving patent protection for new drugs in the world’s poorest nations. … The measures will affect 85 countries, helping more than two billion people, and benefit Africa…

U.S. Trade Deals Have Not Increased Drug Prices In Other Countries

Foreign Affairs: Why U.S. Trade Deals Haven’t Exported U.S. Drug Prices Thomas J. Bollyky, senior fellow for global health, economics, and development at the Council on Foreign Relations (CFR), and adjunct professor of law at Georgetown University “Pharmaceuticals are at the center of the debate over the Trans-Pacific Partnership (TPP),…

Public-Private Partnerships Create Opportunity To Engage China In Global Health Security

Forbes: China’s Contribution To Global Health Security Through Pharma Partnerships Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations and professor at Seton Hall University’s School of Diplomacy and International Relations “…[A] public-private partnership (PPP) can offer an integrated and systematic approach to the development and…

TPP Provisions Could Threaten Access To Affordable Medicines

PLOS Medicine: Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the U.S. and Elsewhere Brook K. Baker, professor at Northeastern University School of Law, discusses the Trans-Pacific Partnership’s (TPP) potential impact on access to affordable medicines if its provisions are ratified, writing, “[Intellectual…

The Lancet Examines Potential Public Health Implications Of TPP

The Lancet: TPP: trade-offs for health behind closed doors “…[T]he final language [of the Trans-Pacific Partnership (TPP)] has complex implications for domestic policies in the participant countries, including for public health. As legislators consider ratifying the agreement, close observers question how future negotiations could be made to yield a more…

CFR Expert Brief Discusses Tobacco Carve-Out In TPP

Council on Foreign Relations: TPP Tobacco Exception Proves the New Rule in Trade In this expert brief, Thomas J. Bollyky, senior fellow for global health, economics, and development, discusses the Trans-Pacific Partnership trade agreement, signed last week, and how the pact “is the first U.S. trade deal to exempt antismoking…

12 Nations Formally Sign TPP; Questions Remain Over U.S. Ratification

Financial Times: As Pacific trade deal is signed pharma holds key to U.S. ratification “U.S. President Barack Obama’s plan to get a vast Pacific Rim trade deal through Congress this year is taking flak from the presidential campaign trail, where disdain for the pact appears to be one of the…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.